Payali, Noradja .

HRN: 16 17 82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2022
METRONIDAZOLE 500MG (TAB)
07/26/2022
08/02/2022
PO
500mg
TID X 7 Days
UTI; G5P4 (4002) Pregnancy Uterine
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: